Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-012259
Filing Date
2024-08-14
Accepted
2024-08-14 16:41:00
Documents
51
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpth-20240630x10q.htm   iXBRL 10-Q 881397
2 EX-31 bpth-20240630xex31.htm EX-31 12492
3 EX-32 bpth-20240630xex32.htm EX-32 6288
  Complete submission text file 0001558370-24-012259.txt   3526532

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpth-20240630.xsd EX-101.SCH 30009
5 EX-101.CAL bpth-20240630_cal.xml EX-101.CAL 30919
6 EX-101.DEF bpth-20240630_def.xml EX-101.DEF 109305
7 EX-101.LAB bpth-20240630_lab.xml EX-101.LAB 219390
8 EX-101.PRE bpth-20240630_pre.xml EX-101.PRE 192256
54 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20240630x10q_htm.xml XML 368243
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS, INC. (Filer) CIK: 0001133818 (see all company filings)

EIN.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36333 | Film No.: 241208910
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)